Skip to main content
Erschienen in: Inflammation 2/2013

01.04.2013

Effect of Lipoxin A4 on Myocardial Ischemia Reperfusion Injury Following Cardiac Arrest in a Rabbit Model

verfasst von: Zhiqiao Chen, Zhe Wu, Congxin Huang, Yan Zhao, Yirong Zhou, Xianlong Zhou, Xingxing Lu, Lele Mao, Siying Li

Erschienen in: Inflammation | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Abstract

In the present study, we investigated the effect of lipoxin A4 on myocardial ischemia–reperfusion injury (IRI) following cardiac arrest (CA) in a rabbit model. Lipoxin A4 is a metabolite of arachidonic acid in the eicosanoid, it is called “brake signal” for its anti-inflammatory activity. Some inflammatory factors (IL-1β, IL-6, TNF-α, and IL-10), NF-κB p65, infarct ratios, apoptotic index, cardiac troponin I (cTnI), hemodynamic and myocardial structures were measured or observed in different groups. Lipoxin A4 inhibits the expression of IL-1β, IL-6, and TNF-α, the values of the infarct ratios, apoptotic index, the level of serum cTnI and NF-κB p65. Meanwhile, it improves the expression of IL-10, hemodynamic, myocardial structure, and function. These indicate that lipoxin A4 mitigates postresuscitation myocardial IRI in which anti-inflammation and suppression of NF-κB activation may play an important role.
Literatur
1.
Zurück zum Zitat de Vreede-Swagemakers, J.J.M., A.P.M. Gorgels, W.I. Dubois-Arbouw, J.W. van Ree, M.J.A.P. Daemen, L.G.E. Houben, and H.J.J. Wellens. 1997. Out-of-hospital cardiac arrest in the 1990s: a population-based study in the Maastricht area on incidence, characteristics and survival. Journal of the American College of Cardiology 30(6): 1500–1505.PubMedCrossRef de Vreede-Swagemakers, J.J.M., A.P.M. Gorgels, W.I. Dubois-Arbouw, J.W. van Ree, M.J.A.P. Daemen, L.G.E. Houben, and H.J.J. Wellens. 1997. Out-of-hospital cardiac arrest in the 1990s: a population-based study in the Maastricht area on incidence, characteristics and survival. Journal of the American College of Cardiology 30(6): 1500–1505.PubMedCrossRef
2.
Zurück zum Zitat Geppert, A., G. Zorn, G.D. Karth, M. Haumer, M. Gwechenberger, J. Koller-Strametz, G. Heinz, K. Huber, and P. Siostrzonek. 2000. Soluble selectins and the systemic inflammatory response syndrome after successful cardiopulmonary resuscitation. Critical Care Medicine 28(7): 2360–2365.PubMedCrossRef Geppert, A., G. Zorn, G.D. Karth, M. Haumer, M. Gwechenberger, J. Koller-Strametz, G. Heinz, K. Huber, and P. Siostrzonek. 2000. Soluble selectins and the systemic inflammatory response syndrome after successful cardiopulmonary resuscitation. Critical Care Medicine 28(7): 2360–2365.PubMedCrossRef
3.
Zurück zum Zitat Adrie, C., M. Adib-Conquy, I. Laurent, M. Monchi, C. Vinsonneau, C. Fitting, F. Fraisse, A.T. Dinh-Xuan, P. Carli, C. Spaulding, J.F. Dhainaut, and J.M. Cavaillon. 2002. Successful cardiopulmonary resuscitation after cardiac arrest as a “sepsis-like” syndrome. Circulation 106(5): 562–568.PubMedCrossRef Adrie, C., M. Adib-Conquy, I. Laurent, M. Monchi, C. Vinsonneau, C. Fitting, F. Fraisse, A.T. Dinh-Xuan, P. Carli, C. Spaulding, J.F. Dhainaut, and J.M. Cavaillon. 2002. Successful cardiopulmonary resuscitation after cardiac arrest as a “sepsis-like” syndrome. Circulation 106(5): 562–568.PubMedCrossRef
4.
Zurück zum Zitat Nolan, J.P., R.W. Neumar, C. Adrie, M. Aibiki, R.A. Berg, B.W. Bbttiger, C. Callaway, R.S. Clark, R.G. Geocadin, E.C. Jauch, K.B. Kern, I. Laurent, W.T. Longstreth, R.M. Merchant, P. Morley, L.J. Morrison, V. Nadkarni, M.A. Peberdy, E.P. Rivers, A. Rodriguez-Nunez, F.W. Sellke, C. Spaulding, K. Sunde, and H.T. Vanden. 2010. Post-cardiac arrest syndrome: epidemiology, pathophysiology, treatment, and prognostication: a scientific statement from the International Liaison Committee on Resuscitation; the American Heart Association Emergency Cardiovascular Care Committee; the Council on Cardiovascular Surgery and Anesthesia; the Council on Cardiopulmonary, Perioperative, and Critical Care; the Council on Clinical Cardiology; the Council on Stroke (Part II). International Emergency Nursing 18(1): 8–28.PubMedCrossRef Nolan, J.P., R.W. Neumar, C. Adrie, M. Aibiki, R.A. Berg, B.W. Bbttiger, C. Callaway, R.S. Clark, R.G. Geocadin, E.C. Jauch, K.B. Kern, I. Laurent, W.T. Longstreth, R.M. Merchant, P. Morley, L.J. Morrison, V. Nadkarni, M.A. Peberdy, E.P. Rivers, A. Rodriguez-Nunez, F.W. Sellke, C. Spaulding, K. Sunde, and H.T. Vanden. 2010. Post-cardiac arrest syndrome: epidemiology, pathophysiology, treatment, and prognostication: a scientific statement from the International Liaison Committee on Resuscitation; the American Heart Association Emergency Cardiovascular Care Committee; the Council on Cardiovascular Surgery and Anesthesia; the Council on Cardiopulmonary, Perioperative, and Critical Care; the Council on Clinical Cardiology; the Council on Stroke (Part II). International Emergency Nursing 18(1): 8–28.PubMedCrossRef
5.
Zurück zum Zitat Cook-Mills, J.M., and T.L. Deem. 2005. Active participation of endothelial cells in inflammation. Journal of Leukocyte Biology 77(4): 487–495.PubMedCrossRef Cook-Mills, J.M., and T.L. Deem. 2005. Active participation of endothelial cells in inflammation. Journal of Leukocyte Biology 77(4): 487–495.PubMedCrossRef
6.
Zurück zum Zitat Boyle, E.J., T.J. Canty, E.N. Morgan, W. Yun, T.H. Pohlman, and E.D. Verrier. 1999. Treating myocardial ischemia–reperfusion injury by targeting endothelial cell transcription. The Annals of Thoracic Surgery 68(5): 1949–1953.PubMedCrossRef Boyle, E.J., T.J. Canty, E.N. Morgan, W. Yun, T.H. Pohlman, and E.D. Verrier. 1999. Treating myocardial ischemia–reperfusion injury by targeting endothelial cell transcription. The Annals of Thoracic Surgery 68(5): 1949–1953.PubMedCrossRef
7.
Zurück zum Zitat Serhan, C.N., and E. Oliw. 2001. Unorthodox routes to prostanoid formation: new twists in cyclooxygenase-initiated pathways. Journal Clinical Investigations 107(12): 1481–1489.CrossRef Serhan, C.N., and E. Oliw. 2001. Unorthodox routes to prostanoid formation: new twists in cyclooxygenase-initiated pathways. Journal Clinical Investigations 107(12): 1481–1489.CrossRef
8.
Zurück zum Zitat Ye, X.H., Y. Wu, P.P. Guo, J. Wang, S.Y. Yuan, Y. Shang, and S.L. Yao. 2010. Lipoxin A4 analogue protects brain and reduces inflammation in a rat model of focal cerebral ischemia reperfusion. Brain Research 1323: 174–183.PubMedCrossRef Ye, X.H., Y. Wu, P.P. Guo, J. Wang, S.Y. Yuan, Y. Shang, and S.L. Yao. 2010. Lipoxin A4 analogue protects brain and reduces inflammation in a rat model of focal cerebral ischemia reperfusion. Brain Research 1323: 174–183.PubMedCrossRef
9.
Zurück zum Zitat Leonard, M.O., K. Hannan, M.J. Burne, D.W. Lappin, P. Doran, P. Coleman, C. Stenson, C.T. Taylor, F. Daniels, C. Godson, N.A. Petasis, H. Rabb, and H.R. Brady. 2002. 15-Epi-16-(para-fluorophenoxy)-lipoxin A(4)-methyl ester, a synthetic analogue of 15-epi-lipoxin A(4), is protective in experimental ischemic acute renal failure. Journal of the American Society of Nephrology 13(6): 1657–1662.PubMedCrossRef Leonard, M.O., K. Hannan, M.J. Burne, D.W. Lappin, P. Doran, P. Coleman, C. Stenson, C.T. Taylor, F. Daniels, C. Godson, N.A. Petasis, H. Rabb, and H.R. Brady. 2002. 15-Epi-16-(para-fluorophenoxy)-lipoxin A(4)-methyl ester, a synthetic analogue of 15-epi-lipoxin A(4), is protective in experimental ischemic acute renal failure. Journal of the American Society of Nephrology 13(6): 1657–1662.PubMedCrossRef
10.
Zurück zum Zitat Peskar, B.M., K. Ehrlich, R. Schuligoi, and B.A. Peskar. 2009. Role of lipoxygenases and the lipoxin A(4)/annexin 1 receptor in ischemia–reperfusion-induced gastric mucosal damage in rats. Pharmacology 84(5): 294–299.PubMedCrossRef Peskar, B.M., K. Ehrlich, R. Schuligoi, and B.A. Peskar. 2009. Role of lipoxygenases and the lipoxin A(4)/annexin 1 receptor in ischemia–reperfusion-induced gastric mucosal damage in rats. Pharmacology 84(5): 294–299.PubMedCrossRef
11.
Zurück zum Zitat Serhan, C.N., A. Jain, S. Marleau, C. Clish, A. Kantarci, B. Behbehani, S.P. Colgan, G.L. Stahl, A. Merched, N.A. Petasis, L. Chan, and T.E. Van Dyke. 2003. Reduced inflammation and tissue damage in transgenic rabbits overexpressing 15-lipoxygenase and endogenous anti-inflammatory lipid mediators. Journal of Immunology 171(12): 6856–6865. Serhan, C.N., A. Jain, S. Marleau, C. Clish, A. Kantarci, B. Behbehani, S.P. Colgan, G.L. Stahl, A. Merched, N.A. Petasis, L. Chan, and T.E. Van Dyke. 2003. Reduced inflammation and tissue damage in transgenic rabbits overexpressing 15-lipoxygenase and endogenous anti-inflammatory lipid mediators. Journal of Immunology 171(12): 6856–6865.
12.
Zurück zum Zitat Takano, T., C.B. Clish, K. Gronert, N. Petasis, and C.N. Serhan. 1998. Neutrophil-mediated changes in vascular permeability are inhibited by topical application of aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogues. Journal of Clinical Investigation 101(4): 819–826.PubMedCrossRef Takano, T., C.B. Clish, K. Gronert, N. Petasis, and C.N. Serhan. 1998. Neutrophil-mediated changes in vascular permeability are inhibited by topical application of aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogues. Journal of Clinical Investigation 101(4): 819–826.PubMedCrossRef
13.
Zurück zum Zitat Takano, T., S. Fiore, J.F. Maddox, H.R. Brady, N.A. Petasis, and C.N. Serhan. 1997. Aspirin-triggered 15-epi-lipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors. The Journal of Experimental Medicine 185(9): 1693–1704.PubMedCrossRef Takano, T., S. Fiore, J.F. Maddox, H.R. Brady, N.A. Petasis, and C.N. Serhan. 1997. Aspirin-triggered 15-epi-lipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors. The Journal of Experimental Medicine 185(9): 1693–1704.PubMedCrossRef
14.
Zurück zum Zitat Devchand, P.R., M. Arita, S. Hong, G. Bannenberg, R.L. Moussignac, K. Gronert, and C.N. Serhan. 2003. Human ALX receptor regulates neutrophil recruitment in transgenic mice: roles in inflammation and host defense. The FASEB Journal 17(6): 652–659.CrossRef Devchand, P.R., M. Arita, S. Hong, G. Bannenberg, R.L. Moussignac, K. Gronert, and C.N. Serhan. 2003. Human ALX receptor regulates neutrophil recruitment in transgenic mice: roles in inflammation and host defense. The FASEB Journal 17(6): 652–659.CrossRef
15.
Zurück zum Zitat Birnbaum, Y., Y. Ye, Y. Lin, S.Y. Freeberg, S.P. Nishi, J.D. Martinez, M.H. Huang, B.F. Uretsky, and J.R. Perez-Polo. 2006. Augmentation of myocardial production of 15-epi-lipoxin-a4 by pioglitazone and atorvastatin in the rat. Circulation 114(9): 929–935.PubMedCrossRef Birnbaum, Y., Y. Ye, Y. Lin, S.Y. Freeberg, S.P. Nishi, J.D. Martinez, M.H. Huang, B.F. Uretsky, and J.R. Perez-Polo. 2006. Augmentation of myocardial production of 15-epi-lipoxin-a4 by pioglitazone and atorvastatin in the rat. Circulation 114(9): 929–935.PubMedCrossRef
16.
Zurück zum Zitat Chen, M.H., L. Xie, T.W. Liu, F.Q. Song, T. He, Z.Y. Zeng, and S.R. Mo. 2007. Epinephrine, but not vasopressin, improves survival rates in an adult rabbit model of asphyxia cardiac arrest. The American Journal of Emergency Medicine 25(5): 509–514.PubMedCrossRef Chen, M.H., L. Xie, T.W. Liu, F.Q. Song, T. He, Z.Y. Zeng, and S.R. Mo. 2007. Epinephrine, but not vasopressin, improves survival rates in an adult rabbit model of asphyxia cardiac arrest. The American Journal of Emergency Medicine 25(5): 509–514.PubMedCrossRef
17.
Zurück zum Zitat Hammel, J.M., C.A. Caldarone, T.L. Van Natta, L.X. Wang, K.F. Welke, W. Li, S. Niles, E. Barner, T.D. Scholz, D.M. Behrendt, and J.L. Segar. 2003. Myocardial apoptosis after cardioplegic arrest in the neonatal lamb. The Journal of Thoracic and Cardiovascular Surgery 125(6): 1268–1275.PubMedCrossRef Hammel, J.M., C.A. Caldarone, T.L. Van Natta, L.X. Wang, K.F. Welke, W. Li, S. Niles, E. Barner, T.D. Scholz, D.M. Behrendt, and J.L. Segar. 2003. Myocardial apoptosis after cardioplegic arrest in the neonatal lamb. The Journal of Thoracic and Cardiovascular Surgery 125(6): 1268–1275.PubMedCrossRef
18.
Zurück zum Zitat Borutaite, V., and G.C. Brown. 2003. Mitochondria in apoptosis of ischemic heart. FEBS Letters 541(1–3): 1–5.PubMedCrossRef Borutaite, V., and G.C. Brown. 2003. Mitochondria in apoptosis of ischemic heart. FEBS Letters 541(1–3): 1–5.PubMedCrossRef
19.
Zurück zum Zitat Song, F., Y. Shan, F. Cappello, F. Rappa, G. Ristagno, T. Yu, V.G. Li, S. Sun, M.H. Weil, and W. Tang. 2010. Apoptosis is not involved in the mechanism of myocardial dysfunction after resuscitation in a rat model of cardiac arrest and cardiopulmonary resuscitation. Critical Care Medicine 38(5): 1329–1334.PubMed Song, F., Y. Shan, F. Cappello, F. Rappa, G. Ristagno, T. Yu, V.G. Li, S. Sun, M.H. Weil, and W. Tang. 2010. Apoptosis is not involved in the mechanism of myocardial dysfunction after resuscitation in a rat model of cardiac arrest and cardiopulmonary resuscitation. Critical Care Medicine 38(5): 1329–1334.PubMed
20.
Zurück zum Zitat Ryan, A., and C. Godson. 2010. Lipoxins: regulators of resolution. Current Opinion in Pharmacology 10(2): 166–172.PubMedCrossRef Ryan, A., and C. Godson. 2010. Lipoxins: regulators of resolution. Current Opinion in Pharmacology 10(2): 166–172.PubMedCrossRef
21.
Zurück zum Zitat Wu, J., A. Wang, Z. Min, Y. Xiong, Q. Yan, J. Zhang, J. Xu, and S. Zhang. 2011. Lipoxin A4 inhibits the production of proinflammatory cytokines induced by beta-amyloid in vitro and in vivo. Biochemistry Biophysics Research Communication 408(3): 382–387.CrossRef Wu, J., A. Wang, Z. Min, Y. Xiong, Q. Yan, J. Zhang, J. Xu, and S. Zhang. 2011. Lipoxin A4 inhibits the production of proinflammatory cytokines induced by beta-amyloid in vitro and in vivo. Biochemistry Biophysics Research Communication 408(3): 382–387.CrossRef
22.
Zurück zum Zitat Baker, N., S.J. O’Meara, M. Scannell, P. Maderna, and C. Godson. 2009. Lipoxin A4: anti-inflammatory and anti-angiogenic impact on endothelial cells. Journal of Immunology 182(6): 3819–3826.CrossRef Baker, N., S.J. O’Meara, M. Scannell, P. Maderna, and C. Godson. 2009. Lipoxin A4: anti-inflammatory and anti-angiogenic impact on endothelial cells. Journal of Immunology 182(6): 3819–3826.CrossRef
23.
Zurück zum Zitat Turer, A.T., and J.A. Hill. 2010. Pathogenesis of myocardial ischemia–reperfusion injury and rationale for therapy. The American Journal of Cardiology 106(3): 360–368.PubMedCrossRef Turer, A.T., and J.A. Hill. 2010. Pathogenesis of myocardial ischemia–reperfusion injury and rationale for therapy. The American Journal of Cardiology 106(3): 360–368.PubMedCrossRef
24.
Zurück zum Zitat Laurent, I., M. Monchi, J.D. Chiche, L.M. Joly, C. Spaulding, B. Bourgeois, A. Cariou, A. Rozenberg, P. Carli, S. Weber, and J.F. Dhainaut. 2002. Reversible myocardial dysfunction in survivors of out-of-hospital cardiac arrest. Journal of the American College of Cardiology 40(12): 2110–2116.PubMedCrossRef Laurent, I., M. Monchi, J.D. Chiche, L.M. Joly, C. Spaulding, B. Bourgeois, A. Cariou, A. Rozenberg, P. Carli, S. Weber, and J.F. Dhainaut. 2002. Reversible myocardial dysfunction in survivors of out-of-hospital cardiac arrest. Journal of the American College of Cardiology 40(12): 2110–2116.PubMedCrossRef
25.
Zurück zum Zitat Ruiz-Bailen, M., D.H.E. Aguayo, S. Ruiz-Navarro, M.A. Diaz-Castellanos, L. Rucabado-Aguilar, F.J. Gomez-Jimenez, S. Martinez-Escobar, R.M. Moreno, and J. Fierro-Roson. 2005. Reversible myocardial dysfunction after cardiopulmonary resuscitation. Resuscitation 66(2): 175–181.PubMedCrossRef Ruiz-Bailen, M., D.H.E. Aguayo, S. Ruiz-Navarro, M.A. Diaz-Castellanos, L. Rucabado-Aguilar, F.J. Gomez-Jimenez, S. Martinez-Escobar, R.M. Moreno, and J. Fierro-Roson. 2005. Reversible myocardial dysfunction after cardiopulmonary resuscitation. Resuscitation 66(2): 175–181.PubMedCrossRef
26.
Zurück zum Zitat Weerateerangkul, P., S. Chattipakorn, and N. Chattipakorn. 2011. Roles of the nitric oxide signaling pathway in cardiac ischemic preconditioning against myocardial ischemia–reperfusion injury. Medical Science Monitor 17(2): A44–A52.CrossRef Weerateerangkul, P., S. Chattipakorn, and N. Chattipakorn. 2011. Roles of the nitric oxide signaling pathway in cardiac ischemic preconditioning against myocardial ischemia–reperfusion injury. Medical Science Monitor 17(2): A44–A52.CrossRef
27.
Zurück zum Zitat Vinten-Johansen, J., R. Jiang, J.G. Reeves, J. Mykytenko, J. Deneve, and L.J. Jobe. 2007. Inflammation, proinflammatory mediators and myocardial ischemia–reperfusion Injury. Hematology/Oncology Clinics of North America 21(1): 123–145.PubMedCrossRef Vinten-Johansen, J., R. Jiang, J.G. Reeves, J. Mykytenko, J. Deneve, and L.J. Jobe. 2007. Inflammation, proinflammatory mediators and myocardial ischemia–reperfusion Injury. Hematology/Oncology Clinics of North America 21(1): 123–145.PubMedCrossRef
28.
Zurück zum Zitat Moro, C., M.G. Jouan, A. Rakotovao, M.C. Toufektsian, O. Ormezzano, N. Nagy, A. Tosaki, J. de Leiris, and F. Boucher. 2007. Delayed expression of cytokines after reperfused myocardial infarction: possible trigger for cardiac dysfunction and ventricular remodeling. America Journal Physiology Heart Circulatory Physiology 293(5): H3014–H3019.CrossRef Moro, C., M.G. Jouan, A. Rakotovao, M.C. Toufektsian, O. Ormezzano, N. Nagy, A. Tosaki, J. de Leiris, and F. Boucher. 2007. Delayed expression of cytokines after reperfused myocardial infarction: possible trigger for cardiac dysfunction and ventricular remodeling. America Journal Physiology Heart Circulatory Physiology 293(5): H3014–H3019.CrossRef
29.
Zurück zum Zitat Baker, R.G., M.S. Hayden, and S. Ghosh. 2011. NF-kappaB, inflammation, and metabolic disease. Cell Metabolism 13(1): 11–22.PubMedCrossRef Baker, R.G., M.S. Hayden, and S. Ghosh. 2011. NF-kappaB, inflammation, and metabolic disease. Cell Metabolism 13(1): 11–22.PubMedCrossRef
30.
Zurück zum Zitat Souza, D.G., C.T. Fagundes, F.A. Amaral, D. Cisalpino, L.P. Sousa, A.T. Vieira, V. Pinho, J.R. Nicoli, L.Q. Vieira, I.M. Fierro, and M.M. Teixeira. 2007. The required role of endogenously produced lipoxin A4 and annexin-1 for the production of IL-10 and inflammatory hyporesponsiveness in mice. Journal of Immunology 179(12): 8533–8543. Souza, D.G., C.T. Fagundes, F.A. Amaral, D. Cisalpino, L.P. Sousa, A.T. Vieira, V. Pinho, J.R. Nicoli, L.Q. Vieira, I.M. Fierro, and M.M. Teixeira. 2007. The required role of endogenously produced lipoxin A4 and annexin-1 for the production of IL-10 and inflammatory hyporesponsiveness in mice. Journal of Immunology 179(12): 8533–8543.
31.
Zurück zum Zitat Jozsef, L., C. Zouki, N.A. Petasis, C.N. Serhan, and J.G. Filep. 2002. Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit peroxynitrite formation, NF-kappa B and AP-1 activation, and IL-8 gene expression in human leukocytes. Processing Nationale Academie Science U S A 99(20): 13266–13271.CrossRef Jozsef, L., C. Zouki, N.A. Petasis, C.N. Serhan, and J.G. Filep. 2002. Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit peroxynitrite formation, NF-kappa B and AP-1 activation, and IL-8 gene expression in human leukocytes. Processing Nationale Academie Science U S A 99(20): 13266–13271.CrossRef
32.
Zurück zum Zitat Yang, J., H. Jiang, J. Yang, J.W. Ding, L.H. Chen, S. Li, and X.D. Zhang. 2009. Valsartan preconditioning protects against myocardial ischemia-reperfusion injury through TLR4/NF-kappaB signaling pathway. Molecular and Cellular Biochemistry 330(1–2): 39–46.PubMedCrossRef Yang, J., H. Jiang, J. Yang, J.W. Ding, L.H. Chen, S. Li, and X.D. Zhang. 2009. Valsartan preconditioning protects against myocardial ischemia-reperfusion injury through TLR4/NF-kappaB signaling pathway. Molecular and Cellular Biochemistry 330(1–2): 39–46.PubMedCrossRef
Metadaten
Titel
Effect of Lipoxin A4 on Myocardial Ischemia Reperfusion Injury Following Cardiac Arrest in a Rabbit Model
verfasst von
Zhiqiao Chen
Zhe Wu
Congxin Huang
Yan Zhao
Yirong Zhou
Xianlong Zhou
Xingxing Lu
Lele Mao
Siying Li
Publikationsdatum
01.04.2013
Verlag
Springer US
Erschienen in
Inflammation / Ausgabe 2/2013
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-012-9567-x

Weitere Artikel der Ausgabe 2/2013

Inflammation 2/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.